Categories newsmakers | 1980sPosted on

Peter C. Adamson ’80

Peter C. Adamson ’80, MD, a pediatric oncologist and scientist at the Children’s Hospital of Philadelphia Research Institute, has been selected to lead the Children’s Oncology Group (COG) in its efforts to find cures for children with cancer. An internationally recognized leader in pediatric cancer drug development, he was elected by principal investigators of more than 200 Children’s Oncology Group sites. “Scientific discovery today is occurring at an unprecedented pace, but the clinical trial system that historically worked so well is showing a diminishing rate of return in our ability to cure children,” said Adamson in a hospital press release. “This system was not designed to rapidly bring findings from the bench to the bedside, and a transformation of the system’s approach is needed to propel translational efforts on an international scale.” A chemistry major at Wesleyan, he earned his MD from Cornell University School of Medicine.
Peter C. Adamson ’80, MD, a pediatric oncologist and scientist at the Children’s Hospital of Philadelphia Research Institute, has been selected to lead the Children’s Oncology Group (COG) in its efforts to find cures for children with cancer. An internationally recognized leader in pediatric cancer drug development, he was elected by principal investigators of more than 200 Children’s Oncology Group sites. “Scientific discovery today is occurring at an unprecedented pace, but the clinical trial system that historically worked so well is showing a diminishing rate of return in our ability to cure children,” said Adamson in a hospital press release. “This system was not designed to rapidly bring findings from the bench to the bedside, and a transformation of the system’s approach is needed to propel translational efforts on an international scale.” A chemistry major at Wesleyan, he earned his MD from Cornell University School of Medicine.